Restart Life Sciences Corp.

CNSX:HEAL Stock Report

Market Cap: CA$1.2m

Restart Life Sciences Management

Management criteria checks 1/4

Restart Life Sciences' CEO is Steve Loutskou, appointed in Oct 2024, has a tenure of less than a year. directly owns 3.11% of the company’s shares, worth CA$36.92K. The average tenure of the management team and the board of directors is 1.8 years and 3.3 years respectively.

Key information

Steve Loutskou

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership3.1%
Management average tenure1.8yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

This Is Why Nova Mentis Life Science Corp.'s (CSE:NOVA) CEO Compensation Looks Appropriate

Dec 09
This Is Why Nova Mentis Life Science Corp.'s (CSE:NOVA) CEO Compensation Looks Appropriate

We Think Nova Mentis Life Science (CSE:NOVA) Can Afford To Drive Business Growth

Dec 07
We Think Nova Mentis Life Science (CSE:NOVA) Can Afford To Drive Business Growth

CEO

Steve Loutskou

less than a year

Tenure

Mr. Steve Loutskou is President and Chief Executive Officer of Restart Life Sciences Corp. (formerly known as Nova Mentis Life Science Corp.) from October 22, 2024. He is Director of Restart Life Sciences...

Leadership Team

NamePositionTenureCompensationOwnership
Rebecca Hudson
Chief Financial Officer2.9yrsCA$72.00k1.17%
CA$ 13.9k
Derek Lloyd Ivany
Executive Chairman1.8yrsno data2.4%
CA$ 28.5k
Steve Loutskou
Presidentless than a yearno data3.11%
CA$ 36.9k
Aylia Mohammadi
President & Chief Scientific Officer of Nova Mentis Biotech Corp.no dataCA$36.00kno data
Kelly Pladson
Corporate Secretaryno datano datano data

1.8yrs

Average Tenure

41yo

Average Age

Experienced Management: HEAL's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Derek Lloyd Ivany
Executive Chairman1.8yrsno data2.4%
CA$ 28.5k
Steve Loutskou
Presidentless than a yearno data3.11%
CA$ 36.9k
Marvin Hausman
Chairman of Scientific Advisory Board3.9yrsno datano data
Georg Hochwimmer
Directorless than a yearno datano data
Kyle Ambert
Member of Scientific Advisory Board3.8yrsno datano data
Julia Perederiy
Member of Scientific Advisory Board3.8yrsno datano data
Gary Harlem
Member of Scientific Advisory Board3.8yrsno datano data
John Molinaro
Member of Scientific Advisory Board2.8yrsno datano data
Viviana Trezza
Member of Scientific Advisory Boardno datano datano data

3.3yrs

Average Tenure

55yo

Average Age

Experienced Board: HEAL's board of directors are considered experienced (3.3 years average tenure).